| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.11B | 72.92B | 80.19B | 87.77B | 85.70B | 67.52B |
| Gross Profit | 18.38B | 18.30B | 20.71B | 22.82B | 23.48B | 18.10B |
| EBITDA | 2.27B | 2.15B | 4.87B | 6.71B | 8.24B | 5.07B |
| Net Income | 518.00M | 405.00M | 2.78B | 3.67B | 5.05B | 2.58B |
Balance Sheet | ||||||
| Total Assets | 74.43B | 76.04B | 75.37B | 72.04B | 69.38B | 60.70B |
| Cash, Cash Equivalents and Short-Term Investments | 13.55B | 13.30B | 18.23B | 19.32B | 22.66B | 19.47B |
| Total Debt | 10.21B | 9.51B | 8.74B | 9.22B | 10.43B | 11.65B |
| Total Liabilities | 31.99B | 31.50B | 32.23B | 33.57B | 35.82B | 32.76B |
| Stockholders Equity | 42.44B | 44.54B | 42.93B | 38.26B | 33.38B | 27.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.17B | 405.00M | -1.80B | 4.24B | 4.24B |
| Operating Cash Flow | 0.00 | -1.61B | 1.56B | -530.00M | 5.14B | 5.04B |
| Investing Cash Flow | 0.00 | -2.46B | -1.13B | -1.53B | -1.02B | -1.07B |
| Financing Cash Flow | 0.00 | -951.00M | -1.77B | -2.19B | -1.72B | 4.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥181.54B | 12.35 | ― | 3.40% | 6.12% | -3.75% | |
67 Neutral | ¥539.90B | 11.82 | 3.68% | 2.35% | -4.47% | -4.52% | |
64 Neutral | ¥25.44B | 12.57 | ― | 3.56% | -5.25% | -4.95% | |
63 Neutral | ¥247.57B | 43.09 | ― | 2.18% | 10.50% | 27.82% | |
63 Neutral | ¥112.83B | 43.70 | ― | 4.78% | -1.25% | 9.33% | |
62 Neutral | ¥2.55T | 18.69 | 15.67% | 1.94% | 9.86% | -1.06% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |